Back to Search
DR. KATHY DIEP NGOC TIEU M.D.
M.D.
Dermatology Physician
NPI: 1811973951IndividualAccepts Medicare
Specialties, Licenses & Credentials
General Practice Physician
General Practice
Code: 208D00000X
0101235150(VA)
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
0101235150(VA)
Education
UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.
PMID 19416912·Proc Natl Acad Sci U S A·2009
7-preclinical
Glutathione dysregulation and the etiology and progression of human diseases.
PMID 19166318·Biol Chem·2009
6-review
Intestinal complications of magnet ingestion in children from the pediatric surgery perspective.
PMID 19224434·Eur J Pediatr Surg·2009
5-case
Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice.
PMID 17389931·Int J Biol Sci·2007
7-preclinical
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.
PMID 16014720·J Neurosci·2005
7-preclinical
Coexisting ovarian malignancy in young women with endometrial cancer.
PMID 16199623·Obstet Gynecol·2005
8-other
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.
PMID 16365298·Proc Natl Acad Sci U S A·2005
7-preclinical
Novel 2-(substituted phenyl)benzimidazole derivatives with potent activity against IgE, cytokines, and CD23 for the treatment of allergy and asthma.
PMID 15588078·J Med Chem·2004
7-preclinical
Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the beta3 subunit.
PMID 14690453·Biochem J·2004
7-preclinical
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
PMID 15236401·Ann Neurol·2004
7-preclinical
MPTP as a mitochondrial neurotoxic model of Parkinson's disease.
PMID 15377875·J Bioenerg Biomembr·2004
6-review
Gaussian filters and filter synthesis using a Hermite/Laguerre neural network.
PMID 15387262·IEEE Trans Neural Netw·2004
8-other
Nitric oxide and reactive oxygen species in Parkinson's disease.
PMID 12938735·IUBMB Life·2003
6-review
D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease.
PMID 12975474·J Clin Invest·2003
7-preclinical
Free radical and nitric oxide toxicity in Parkinson's disease.
PMID 12442666·Adv Neurol·2003
7-preclinical
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration.
PMID 12702778·Proc Natl Acad Sci U S A·2003
7-preclinical
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
PMID 12721370·Proc Natl Acad Sci U S A·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3700 JOSEPH SIEWICK DR, SUITE 404
FAIRFAX, VA 22033 - Phone
- (703) 620-8900
Quick Facts
- NPI
- 1811973951
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile